S&P 500   4,971.90 (-0.78%)
DOW   37,855.71 (+0.21%)
QQQ   417.33 (-1.44%)
AAPL   164.64 (-1.44%)
MSFT   400.51 (-0.93%)
META   484.41 (-3.47%)
GOOGL   154.09 (-1.23%)
AMZN   175.53 (-2.06%)
TSLA   149.51 (-0.28%)
NVDA   811.76 (-4.13%)
AMD   148.70 (-4.11%)
NIO   3.84 (-4.00%)
BABA   68.63 (-0.36%)
T   16.34 (+0.06%)
F   12.11 (+0.41%)
MU   107.36 (-4.08%)
GE   149.14 (-2.48%)
CGC   7.98 (+1.92%)
DIS   111.55 (-0.78%)
AMC   3.24 (+10.96%)
PFE   25.85 (+1.81%)
PYPL   62.03 (-0.11%)
XOM   120.11 (+1.34%)
S&P 500   4,971.90 (-0.78%)
DOW   37,855.71 (+0.21%)
QQQ   417.33 (-1.44%)
AAPL   164.64 (-1.44%)
MSFT   400.51 (-0.93%)
META   484.41 (-3.47%)
GOOGL   154.09 (-1.23%)
AMZN   175.53 (-2.06%)
TSLA   149.51 (-0.28%)
NVDA   811.76 (-4.13%)
AMD   148.70 (-4.11%)
NIO   3.84 (-4.00%)
BABA   68.63 (-0.36%)
T   16.34 (+0.06%)
F   12.11 (+0.41%)
MU   107.36 (-4.08%)
GE   149.14 (-2.48%)
CGC   7.98 (+1.92%)
DIS   111.55 (-0.78%)
AMC   3.24 (+10.96%)
PFE   25.85 (+1.81%)
PYPL   62.03 (-0.11%)
XOM   120.11 (+1.34%)
S&P 500   4,971.90 (-0.78%)
DOW   37,855.71 (+0.21%)
QQQ   417.33 (-1.44%)
AAPL   164.64 (-1.44%)
MSFT   400.51 (-0.93%)
META   484.41 (-3.47%)
GOOGL   154.09 (-1.23%)
AMZN   175.53 (-2.06%)
TSLA   149.51 (-0.28%)
NVDA   811.76 (-4.13%)
AMD   148.70 (-4.11%)
NIO   3.84 (-4.00%)
BABA   68.63 (-0.36%)
T   16.34 (+0.06%)
F   12.11 (+0.41%)
MU   107.36 (-4.08%)
GE   149.14 (-2.48%)
CGC   7.98 (+1.92%)
DIS   111.55 (-0.78%)
AMC   3.24 (+10.96%)
PFE   25.85 (+1.81%)
PYPL   62.03 (-0.11%)
XOM   120.11 (+1.34%)
S&P 500   4,971.90 (-0.78%)
DOW   37,855.71 (+0.21%)
QQQ   417.33 (-1.44%)
AAPL   164.64 (-1.44%)
MSFT   400.51 (-0.93%)
META   484.41 (-3.47%)
GOOGL   154.09 (-1.23%)
AMZN   175.53 (-2.06%)
TSLA   149.51 (-0.28%)
NVDA   811.76 (-4.13%)
AMD   148.70 (-4.11%)
NIO   3.84 (-4.00%)
BABA   68.63 (-0.36%)
T   16.34 (+0.06%)
F   12.11 (+0.41%)
MU   107.36 (-4.08%)
GE   149.14 (-2.48%)
CGC   7.98 (+1.92%)
DIS   111.55 (-0.78%)
AMC   3.24 (+10.96%)
PFE   25.85 (+1.81%)
PYPL   62.03 (-0.11%)
XOM   120.11 (+1.34%)
Free Trial

Galmed Pharmaceuticals (GLMD) SEC Filings & 10K Form

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)
Free GLMD Stock Alerts
$0.38
0.00 (-0.05%)
(As of 11:42 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media

Recent Galmed Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
04/04/2024
3:54 PM		Galmed Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/15/2024
8:13 AM		Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
1:14 PM		CVI Investments, Inc. (Filed by)
Galmed Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2024
8:52 AM		BIOTECHNOLOGY VALUE FUND L P (Filed by)
Galmed Pharmaceuticals (Subject)
Form SC 13G/A
11/29/2023
11:15 PM		Galmed Pharmaceuticals (Filer)
Form EFFECT
11/22/2023
3:48 PM		Galmed Pharmaceuticals (Filer)
Form POS AM
11/20/2023
3:37 PM		Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2023
7:51 AM		Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/22/2023
3:15 PM		Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/21/2023
6:30 AM		Galmed Pharmaceuticals (Filer)
Form 6-K/A
09/20/2023
3:30 PM		Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/21/2023
9:12 AM		CVI Investments, Inc. (Filed by)
Galmed Pharmaceuticals (Subject)
Form SC 13G
07/18/2023
8:23 AM		Galmed Pharmaceuticals (Filer)
Form 424B4
07/18/2023
8:25 AM		Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2023
11:15 PM		Galmed Pharmaceuticals (Filer)
Form EFFECT
07/14/2023
8:44 AM		Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/13/2023
4:08 PM		Galmed Pharmaceuticals (Filer)
Form F-1/A
07/12/2023
4:29 PM		Galmed Pharmaceuticals (Filer)
Form F-1/A
07/10/2023
7:10 AM		Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2023
7:37 AM		Galmed Pharmaceuticals (Filer)
Form F-1/A
06/28/2023
7:40 AM		Galmed Pharmaceuticals (Subject)
Form FWP
06/01/2023
7:14 AM		Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2023
6:00 AM		Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/09/2023
6:14 AM		Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:GLMD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
1970’s computer coder issues shocking A.I. warning
TradeSmith